Quarterly report pursuant to Section 13 or 15(d)

Equity Incentive Plan (Tables)

v3.19.3
Equity Incentive Plan (Tables)
9 Months Ended
Sep. 30, 2019
Equity Incentive Plan  
Schedule of stock option activity

The following is a summary of stock option activity under the Plans for the nine months ended September 30, 2019 and 2018:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-Average

 

 

Number of

 

Weighted- Average

 

Contractual Life

 

    

Options

    

Exercise Price

    

(In Years)

Outstanding at December 31, 2018

 

138,324

 

$

34.17

 

6.51

Granted

 

49,994

 

 

7.20

 

 

Forfeited

 

(4,869)

 

 

9.19

 

 

Expired

 

(3,237)

 

 

16.25

 

 

Outstanding at September 30, 2019

 

180,212

 

$

27.68

 

6.57

Exercisable at September 30, 2019

 

120,527

 

$

37.25

 

5.32

Vested and Expected to Vest at September 30, 2019

 

180,212

 

$

27.68

 

6.57

 

 

  

 

 

  

 

  

Outstanding at December 31, 2017

 

127,310

 

$

38.14

 

5.83

Granted

 

27,687

 

 

8.55

 

 

Forfeited

 

(1,567)

 

 

15.95

 

 

Expired

 

(7,684)

 

 

19.51

 

 

Outstanding at September 30, 2018

 

145,746

 

$

33.74

 

6.09

Exercisable at September 30, 2018

 

96,863

 

$

43.10

 

5.43

Vested and Expected to Vest at September 30, 2018

 

145,746

 

$

33.74

 

6.09

 

Schedule of weighted average assumptions

For the nine months ended September 30, 2019 and 2018, the fair value of each option grant has been estimated on the date of grant using the Black-Scholes Option Pricing Model with the following weighted-average assumptions:

 

 

 

 

 

 

 

 

    

2019

    

2018

 

Risk-Free Interest Rate

 

1.82

%  

1.82

%

Expected Life

 

5.00

years

8.02

years

Expected Volatility

 

152

%  

158

%

Expected Dividend Yield

 

 0

%  

 0

%

 

Schedule of restricted stock activity

The following is a summary of restricted stock activity for the nine months ended September 30, 2019 and September 30, 2018:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted- Average

 

 

Number of

 

Weighted- Average

 

Remaining

 

    

Shares

    

Grant Date Fair Value

    

Recognition Period

Nonvested Outstanding at December 31, 2018

 

121,478

 

$

8.84

 

  

Vested

 

(55,335)

 

 

8.94

 

  

Forfeited

 

(7,659)

 

 

8.86

 

 

Nonvested Outstanding at September 30, 2019

 

58,484

 

$

8.76

 

1.73

Nonvested Outstanding at December 31, 2017

 

6,865

 

 

22.81

 

  

    Awarded

 

125,989

 

 

8.55

 

 

    Vested

 

(3,593)

 

 

22.81

 

 

    Forfeited

 

(3,349)

 

 

8.63

 

  

Nonvested Outstanding at September 30, 2018

 

125,912

 

$

8.92

 

2.50

 

Schedule of stock-based compensation expense

The total stock-based compensation expense for employees and non-employees is included in the accompanying Condensed Consolidated Statements of Operations and as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

September 30, 

 

September 30, 

 

    

2019

    

2018

    

2019

    

2018

Research and Development

 

$

42,062

 

$

85,106

 

$

165,213

 

$

192,081

General and Administrative

 

 

137,660

 

 

244,373

 

 

483,605

 

 

428,254

Total Stock-Based Compensation Expense

 

$

179,722

 

$

329,479

 

$

648,818

 

$

620,335